A 104 weeks, double-blind trial that included 3297 patients suffering from type 2 diabetes and atherosclerosis cardiovascular disease was randomized to Semaglutide 0.5 mg once a week, Semaglutide 1 mg, once a week again, or placebo along with standard-of-care for an average study observation period of 2.1 years
Outcomes Main outcome was the occurrence of major cardiovascular event (MACE) which was defined as hospitalization for acute coronary syndrome (ICD-10: I20.0, I21-22) or cerebrovascular event (ICD-10: I60,61,63,64) or all-cause death
P.BarkhofF.et al
Grzadzinski R, Amso D, Landa R, Watson L, Guralnick M, Zwaigenbaum L, Dek G, Estes A, Brian J, Bath K, Elison J, Abbeduto L, Wolff J, Piven J (2021) Pre-symptomatic intervention for autism spectrum disorder (ASD): defining a research agenda
Conclusion On a GLP1 medication, you are eating less, which means quality matters more than ever
In recent years, the impact of the plateau environment on male reproductive health has received attention, but there is limited research on the male reproductive system in plateau hypoxic environments [4, 5]